Braconnier, Philippe <br/><br/>
Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Jun 2012 
 - 2547-53 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfr627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibiotics, Antineoplastic--adverse effects<br/>Antibodies, Anti-Idiotypic--adverse effects<br/>Drug Combinations<br/>Female<br/>Follow-Up Studies<br/>Graft Rejection<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Failure, Chronic--mortality<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--adverse effects<br/>Neoplasms--epidemiology<br/>Prognosis<br/>Receptors, Interleukin-2--immunology<br/>Retrospective Studies<br/>Survival Rate<br/>Tacrolimus--adverse effects